BX Home
Pharmaceutical Approvals
Qualitest Receives FDA Approval For Dexamethasone Elixir, USP, 0.

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

Register using your

account Register for Beta

PHARMACEUTICAL APPROVALS back to topic

0.02 Mg)

/PRNewswire/ -- Qualitest Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved dexamethasone elixir, USP, 0.5mg/ 5 mL and Orsythia�� Tablets (levonorgestrel and ethinyl estradiol tablets, USP, 0...

TheStreet.com. Published on May 18, 2011

Read the full Article

report

save

Reactions to Qualitest Receives FDA Approval For Dexamethasone Elixir, USP, 0.5mg/ 5 ML And Orsythia�� Tablets (Levonorgestrel And Ethinyl Estradiol Tablets, USP, 0.1 Mg/0.02 Mg)

Date

Type Channel Author

Search Cancel

Qualitest Receives FDA Approval For Dexamethasone Elixir, USP, 0.5mg/ 5 ML And Orsythia��� Tablets (Levonorgestrel And Ethinyl Estradiol Tablets, USP, 0.1 Mg/0.02 Mg)

Reactions to Qualitest Receives FDA Approval For Dexamethasone Elixir, USP, 0.5mg/ 5 ML And Orsythia��� Tablets (Levonorgestrel And Ethinyl Estradiol Tablets, USP, 0.1 Mg/0.02 Mg)

Join Business Exchange

Member sign in

Qualitest Receives FDA Approval For Dexamethasone Elixir, USP, 0.5mg/ 5 ML And Orsythia�� Tablets (Levonorgestrel And Ethinyl Estradiol Tablets, USP, 0.1 Mg/0.02 Mg)

Reactions to Qualitest Receives FDA Approval For Dexamethasone Elixir, USP, 0.5mg/ 5 ML And Orsythia�� Tablets (Levonorgestrel And Ethinyl Estradiol Tablets, USP, 0.1 Mg/0.02 Mg)